272 related articles for article (PubMed ID: 15086487)
1. Treatment of refractory Wegener's granulomatosis with antithymocyte globulin (ATG): an open study in 15 patients.
Schmitt WH; Hagen EC; Neumann I; Nowack R; Flores-Suárez LF; van der Woude FJ;
Kidney Int; 2004 Apr; 65(4):1440-8. PubMed ID: 15086487
[TBL] [Abstract][Full Text] [Related]
2. Compassionate treatment of Wegener's granulomatosis with rabbit anti-thymocyte globulin.
Hagen EC; de Keizer RJ; Andrassy K; van Boven WP; Bruijn JA; van Es LA; van der Woude FJ
Clin Nephrol; 1995 Jun; 43(6):351-9. PubMed ID: 7554518
[TBL] [Abstract][Full Text] [Related]
3. Prolonged treatment of refractory Wegener's granulomatosis with 15-deoxyspergualin: an open study in seven patients.
Schmitt WH; Birck R; Heinzel PA; Göbel U; Choi M; Warnatz K; Peter HH; van der Woude FJ
Nephrol Dial Transplant; 2005 Jun; 20(6):1083-92. PubMed ID: 15827051
[TBL] [Abstract][Full Text] [Related]
4. Deoxyspergualin in relapsing and refractory Wegener's granulomatosis.
Flossmann O; Baslund B; Bruchfeld A; Tervaert JW; Hall C; Heinzel P; Hellmich B; Luqmani RA; Nemoto K; Tesar V; Jayne DR
Ann Rheum Dis; 2009 Jul; 68(7):1125-30. PubMed ID: 18713783
[TBL] [Abstract][Full Text] [Related]
5. Survival and vasculitis activity in patients with end-stage renal disease due to Wegener's granulomatosis.
Haubitz M; Koch KM; Brunkhorst R
Nephrol Dial Transplant; 1998 Jul; 13(7):1713-8. PubMed ID: 9681717
[TBL] [Abstract][Full Text] [Related]
6. High-dose azathioprine pulse therapy as a new treatment option in patients with active Wegener's granulomatosis and lupus nephritis refractory or intolerant to cyclophosphamide.
Benenson E; Fries JW; Heilig B; Pollok M; Rubbert A
Clin Rheumatol; 2005 Jun; 24(3):251-7. PubMed ID: 15940558
[TBL] [Abstract][Full Text] [Related]
7. Etanercept plus standard therapy for Wegener's granulomatosis.
Wegener's Granulomatosis Etanercept Trial (WGET) Research Group
N Engl J Med; 2005 Jan; 352(4):351-61. PubMed ID: 15673801
[TBL] [Abstract][Full Text] [Related]
8. Advances in the therapy of Wegener's granulomatosis.
Hellmich B; Lamprecht P; Gross WL
Curr Opin Rheumatol; 2006 Jan; 18(1):25-32. PubMed ID: 16344616
[TBL] [Abstract][Full Text] [Related]
9. Use of a cyclophosphamide-induction methotrexate-maintenance regimen for the treatment of Wegener's granulomatosis: extended follow-up and rate of relapse.
Langford CA; Talar-Williams C; Barron KS; Sneller MC
Am J Med; 2003 Apr; 114(6):463-9. PubMed ID: 12727579
[TBL] [Abstract][Full Text] [Related]
10. B-cell depletion with rituximab for refractory head and neck Wegener's granulomatosis: a cohort study.
Martinez Del Pero M; Chaudhry A; Jones RB; Sivasothy P; Jani P; Jayne D
Clin Otolaryngol; 2009 Aug; 34(4):328-35. PubMed ID: 19673980
[TBL] [Abstract][Full Text] [Related]
11. [Wegener's granulomatosis and microscopic polyangiitis].
Pagnoux C
Rev Prat; 2008 Mar; 58(5):522-32. PubMed ID: 18524109
[TBL] [Abstract][Full Text] [Related]
12. Rituximab for refractory Wegener's granulomatosis: report of a prospective, open-label pilot trial.
Keogh KA; Ytterberg SR; Fervenza FC; Carlson KA; Schroeder DR; Specks U
Am J Respir Crit Care Med; 2006 Jan; 173(2):180-7. PubMed ID: 16224107
[TBL] [Abstract][Full Text] [Related]
13. Treatment strategies and outcome of induction-refractory Wegener's granulomatosis or microscopic polyangiitis: analysis of 32 patients with first-line induction-refractory disease in the WEGENT trial.
Seror R; Pagnoux C; Ruivard M; Landru I; Wahl D; Rivière S; Aussant S; Mahr A; Cohen P; Mouthon L; Guillevin L;
Ann Rheum Dis; 2010 Dec; 69(12):2125-30. PubMed ID: 20643762
[TBL] [Abstract][Full Text] [Related]
14. Monthly intravenous pulse cyclophosphamide therapy in Wegener's granulomatosis.
Lê Thi Huong D; Papo T; Piette JC; Wechsler B; Blétry O; Lamas G; Baumelou A; Le Hoang P; Pennaforte JL; Valcke JC; Godeau P
Clin Exp Rheumatol; 1996; 14(1):9-16. PubMed ID: 8697666
[TBL] [Abstract][Full Text] [Related]
15. Rituximab (MABTHERA) and severe polyangiitis. An option for patients informed of the uncertainties.
Prescrire Int; 2015 Jun; 24(161):145-8. PubMed ID: 26436161
[TBL] [Abstract][Full Text] [Related]
16. Rituximab in the treatment of refractory scleritis in patients with granulomatosis with polyangiitis (Wegener's).
Recillas-Gispert C; Serna-Ojeda JC; Flores-Suárez LF
Graefes Arch Clin Exp Ophthalmol; 2015 Dec; 253(12):2279-84. PubMed ID: 26507398
[TBL] [Abstract][Full Text] [Related]
17. [Wegener's granulomatosis. Report of a pediatric case and review of the literature].
Ayala de la Cruz Mdel C; González Díaz R; López Lara ND
Rev Alerg Mex; 2003; 50(2):71-5. PubMed ID: 12825492
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic and therapeutic aspects of the surgical approach to Wegener's granulomatosis.
Flye MW; Mundinger GH; Fauci AS
J Thorac Cardiovasc Surg; 1979 Mar; 77(3):331-7. PubMed ID: 762975
[TBL] [Abstract][Full Text] [Related]
19. Infliximab or rituximab for refractory Wegener's granulomatosis: long-term follow up. A prospective randomised multicentre study on 17 patients.
de Menthon M; Cohen P; Pagnoux C; Buchler M; Sibilia J; Détrée F; Gayraud M; Khellaf M; Penalba C; Legallicier B; Mouthon L; Guillevin L
Clin Exp Rheumatol; 2011; 29(1 Suppl 64):S63-71. PubMed ID: 21586199
[TBL] [Abstract][Full Text] [Related]
20. Urinary bladder cancer in Wegener's granulomatosis: risks and relation to cyclophosphamide.
Knight A; Askling J; Granath F; Sparen P; Ekbom A
Ann Rheum Dis; 2004 Oct; 63(10):1307-11. PubMed ID: 15130900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
